ReviewMicromachines2025
Next-Gen Healthcare Devices: Evolution of MEMS and BioMEMS in the Era of the Internet of Bodies for Personalized Medicine.
Review in Micromachines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid evolution of healthcare technology is being driven by advancements in Micro-Electro-Mechanical Systems (MEMS), BioMEMS (Biological MEMS), and the expanding concept of the Internet of Bodies (IoB). This review explores the convergence of these three domains and their transformative impact on personalized medicine (PM), with a focus on smart, connected biomedical devices. Starting from the historical development of MEMS for medical sensing and diagnostics, the review traces the emergence of BioMEMS as biocompatible, minimally invasive solutions for continuous monitoring and real-time intervention. The integration of such devices within the IoB ecosystem enables data-driven, remote, and predictive healthcare, offering tailored diagnostics and treatment for chronic and acute conditions alike. The paper classifies IoB-associated technologies into non-invasive, invasive, and incorporated devices, reviewing wearable systems such as smart bracelets, e-tattoos, and smart footwear, as well as internal devices including implantable and ingestible. Alongside these opportunities, significant challenges persist, particularly in device biocompatibility, data interoperability, cybersecurity, and ethical regulation. By synthesizing recent advances and critical perspectives, this review aims to provide a comprehensive understanding of the current landscape, clinical potential, and future directions of MEMS, BioMEMS, and IoB-enabled personalized healthcare.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.